miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia

The introduction of imatinib has led to remarkable improvement in overall survival of the patients with chronic myeloid leukemia (CML). Despite its success, around 20–25% of the patients do not ach...